Sowjanya Kalidindi Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 5.88%
- Profit Growth -28.57%
- Ebitda -7.06%
- Net Worth
- Total Assets %
About Sowjanya Kalidindi Biotech
Sowjanya Kalidindi Biotech Private Limited (SKBPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2006 and has a history of 18 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jaya Chintalapati, Kalidindi Raju, and Chalapathi Kalidindi serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U01403TG2006PTC050998
- Company No.
050998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sowjanya Kalidindi Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chalapathi Kalidindi  | Director | 11-Apr-2008 | Current |
| Jaya Chintalapati | Director | 20-Mar-2019 | Current |
| Kalidindi Raju | Director | 28-Aug-2006 | Current |
Financial Performance of Sowjanya Kalidindi Biotech.
Sowjanya Kalidindi Biotech Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.88% increase. The company also saw a substantial fall in profitability, with a 28.57% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sowjanya Kalidindi Biotech?
In 2018, Sowjanya Kalidindi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aryavarta Biotech Private LimitedJaya Chintalapati, Kalidindi Raju and 1 more are mutual person
- Pokepola Enterprises Llp
Jaya Chintalapati is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sowjanya Kalidindi Biotech?
Unlock and access historical data on people associated with Sowjanya Kalidindi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sowjanya Kalidindi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sowjanya Kalidindi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
